The development of methods to regenerate human tissues and organs by tissue engineering (TE), will have a dramatic influence on many medical specialities in the future. The essence of plastic surgery is to reconstruct disrupted and damaged tissues by the use of a plethora of techniques spanning from small local skin flaps to highly advanced microsurgery and free composite grafts. However, these methods only focus on moving tissue from one part of the patient to another without actual regeneration. To be able to take the next step in development of the speciality it is of necessity to address this issue. Hence it follows naturally that plastic surgeons lead and represent the driving force of the development within the research of tissue engineering. In this paper we would like to present active research and also give an overview of areas in tissue engineering that are of special interest to the plastic surgeon.
PLASTIC SURGERY -A SPECIALITY FOCUSED ON RECONSTRUCTION
The main task of reconstructive plastic surgery is to reconstruct malformed and surgical or accidentally traumatized tissues and organs, with an optimal functional and aesthetical result. This is performed mainly through moving tissues from one body region (donor site) to the disrupted region (recipient site). The fundamental principles were described as early as 1600 years B.C. in Eber's papyrus and also by Sushutra Samhita of India (600 years B.C.) (1). In both these works methods for surgical reconstruction of the nose and ears were described.
Even if their techniques have been developed and refined throughout the years, many of the fundamental principals are still the same. These include the transfer of tissue from an uninjured area of the patient to an injured area lacking tissue or function. The transfer can be performed using two fundamental methods: a free tissue graft or a pedicled tissue graft. A free tissue graft involves removal of tissue from its blood supply in the donor area, which implies that the graft depends on passive supply of nutrition from the recipient area during the healing phase, e.g. a free full thickness skin graft. Using pedicled graft one moves a tissue bulk, retaining its original circulation, to cover a receiving area with unreliable or absent circulation or to transfer such a large bulk of tissue as passive nutritional support is not successful, e.g. a pedicled m. latissimus dorsi flap. Pedicled tissue can be transferred either by keeping existing circulation intact -stemmed pedicled graft, or as a free pedicled graft -the circulation is then divided and with microsurgical techniques re-connected to suitable vessels in the vicinity of the recipient area. With these techniques the majority of tissue types can be transferred and used for reconstructive purposes. They are, nevertheless, associated with certain problems; e.g. donor site morbidity (i.e. loss of function and following deformity), long and complicated operations, and limited access to uninjured tissue suitable for grafting. Furthermore this means compensating only of missing bulk, and involves no compensation of cellular functions.
STAR TREK AND FRANKENSTEIN
Mankind has always dreamed about recreating damaged and lost tissues through regeneration. Existing examples of this ability is found mainly in the animal kingdom but also in human foetuses during the first two trimesters when injuries to the skin heals through complete regeneration of the skin's components instead of scar formation as in adult humans.
Thoughts of how to recreate human tissues can be found abundantly in the popular press, spanning from Dr McCoy's fantastic methods of treatment in the Star Trek movies to Professor Frankenstein's (in)famous monster. In medical research, several scientists have pursued these ideas, but it is only during the last decades where methods have started to reach clinical applications.
Methods aimed to recreate the patients own (autologous) viable tissue is usually summarized using the term "tissue engineering" and can arbitrarily be divided into two main principles:
• Methods where autologous cells are cultured outside the body (in vitro) and transplanted back to the patient either by means of a 3D-biodegradable matrix as carrier in a tissue structure or in a cell suspension. • Methods where the body's tissue is stimulated and given the right prerequisites to regenerate tissue in vivo, with the assistance of implantations of specially constructed materials or application of substances which regulate cell functions, i.e. guided tissue regeneration.
Tissue engineering used clinically today combine these two principles to achieve an as effective and complete regeneration as possible. Many of the techniques for tissue engineering developed and used today have a direct connection to the field of plastic surgery, and plastic surgery is probably one of the specialities of medicine that will have the fastest and strongest influence on this new era in medicine. In this paper we present some of the areas of tissue engineering that are presently, or will within a short period of time, be of clinical use in plastic surgery. This article does not claim to completely cover the entire field of tissue engineering, rather to shed some light upon the possibilities these new methods hold for reconstructive and aesthetic plastic surgery and also the new demands on plastic surgeons and what they convey.
SKIN -THE BODY'S LARGEST ORGAN
The first steps towards what we today call tissue engineering took place on the fundamental tissue of plastic surgery -the skin. This probably explains the close connections between plastic surgery and tissue engineering. In 1898 Ljunggren successfully kept human skin alive in a laboratory environment, he also managed to graft it back to the donor after some time ex vivo (2). Even if this "tissue incubation" differs somewhat from what we today call cell cultivation it was the starting-point for the development of the methods for cultivation of human skin cells in vitro, that are used today.
In the beginning of the 20 th century cultivation conditions, as far as cultivation techniques and nutritional mediums are concerned, were optimised. One succeeded in not only keeping cells of the skin alive, but also had them to replicate and proliferate in vitro. The techniques to have skin cells to grow from epidermal biopsies, called explants, also meant the possibility to study these cells, keratinocytes, in a standardised fashion. One could show keratinocytes growing in stratified formations resembling normal epidermis and that the (in number) expanded cells could be grafted back to the donor as autografts. At this time the outgrowth of cells was very limited and the cells could not be subcultivated and hence the expansion number was quite small. The method had no clinical use, but was (is) a very important research tool for studying skin.
During the 1950's and 1960's methods developed to enzymatically separate the epidermis from the dermis, and also the keratinocytes from each other, into a single cell suspension. This meant that cells from a small skin biopsy could be seeded upon a considerably larger culture area in vitro generating a larger expansion rate. Unfortunately it was showed that the keratinocytes quickly differentiated, which made it impossible to subcultivate them and also to gain stratified sheets of keratinocytes. A notable improvement was found when the cells were grown on collagen-coated culture plates. Although the success was limited even with cultivation on collagen, one began to understand the need of dermal components and connective tissue for optimal conditions of keratinocyte culture.
Of major importance was the discovery of the epidermal growth factor, EGF, which showed to be important for keratinocyte proliferation (3). The real breakthrough came during the 1970's when Jim Rheinwald and Howard Green developed methods for cultivation of human cells and, in 1975, could present their legendary methods to cultivate human keratinocytes with a greater expansion rate and in the form of stratified sheets which could be grafted (4). In 1983, using these methods, the first two patients were grafted with autologous in vitro cultured keratinocytes performed at Shriner's Burn Institute by the plastic surgeons Gallico and O'Connor (5).
The method described by Rheinwald and Green was based on co-culture of the patients keratinocytes and 3T3 cells (Swiss mouse fibroblasts whose proliferation have been stopped through radiation or cytotoxin treatment but whose ability to stimulate keratinocyte cell growth while inhibiting the growth of human fibroblasts is retained), gave the possibility to largely expand the patients own skin (epidermis). To day we can go from a 1 cm 2 biopsy to about 1,5 m 2 of epidermal grafts in approximately 4 weeks.
Unlimited access to the patient's own skin (epidermis) involves a dramatic improvement in burn care treatment, and today most large burn centres have the possibility for own skin culture or have contacts with centres that have the facilities and knowledge. The cultured skin graft saves lives, but the methods used today provide far from optimal results and several quality-problems have yet to be overcome. Although optimisation of culture conditions, meaning that sufficient epidermal graft area to cover the whole body of an adult can be created within 4 weeks, the lag-time can be too long for a seriously burned patient. The production process is complicated and draws large personal resources, which involves a relatively high cost. Most important, these cultured grafts, which are used to cover deep dermal and full thickness burns, today only involves epidermal cells and that they are applied on a surface of cicatrizing connective tissue. The end result can perhaps be cosmetically attractive for the eye, but has a low biomechanical durability with frequent blistering and new wounds developing frequently. Therefore, the cultured epidermal graft must be combined with a recreated dermal skin component, as the dermis holds the strength and pliability in the normal skin.
Many have tried, during the last decades, to culture the cells which build up the dermis and subsequently bring them together with keratinocytes, in vitro, in a 3D-matrix with the hope of regenerating a graftable complete epidermal-dermal skin structure. This is yet to be performed, as to our knowledge no one has successfully had the neodermis to heal by adequate means. Not surprisingly, when we think about the long cultivation period needed and thus the risk of changing phenotypes of the involved cells.
As often is the case, an easier method where you let the body itself take care of most of the work has been more successful. It has been shown that the network of collagen and other matrix components that remains after all the cells are removed from the dermis can function as a scaffold for regeneration of dermis (6). When all of the cells are removed from the dermis even the antigenicity is removed, which makes possible the use of allogenous material, and today there are both cellfree human dermis and dermal substitutes of collagen lattices available as commercial products.
When the cellfree dermis is applied to the wound, after necrotic tissue has been removed, the surrounding tissues do not notice the area as a wound area any longer. The result is a migration of tissue-and vessel-cells into the cellfree dermal scaffold, with a complete regeneration of dermis instead of scar formation as otherwise is the case. A very good example of the type of tissue engineering known as guided tissue regeneration. The final regeneration of epidermis can be caused either with cultured keratinocytes or with ultra thin split-thickness skin grafts ( Fig. 1A) .
We have in our group gone a step further and also addressed the issues of time and cost factors. At an early stage (after one generation of subculture) the autologous keratinocytes can be seeded as single cells on cellfree dermis, and immediately transferred back to the patient as a graft, shortening cultivation time to approximately a week. The complicated and expensive graft development is avoided and the epidermal cells are early returned to a normal in vivo environment. This reduces the risk of phenotype changes and a regeneration of the dermis while simultaneously regenerating the epidermis, with essentially better function and cosmetic end results.
Even if these methods up to now have been used for the treatment of large acute burn wounds, they are nowadays established and have even started to be used for other patient groups e.g. treatment of large birthmarks and late reconstructions of burns. The possibility of complete regeneration of skin brings fantastic opportunities to the reconstructive plastic surgery area. Even within aesthetic plastic surgery have cellfree dermis been used for filling purposes, e.g. lip-enhancement.
In gene therapy the main objective and use of keratinocytes have dealt with transfected cells for growth factors, involved in the wound healing process. Woundhealing being central in plastic surgical and plastic surgeons have also been strongly involved in this work. There are now implications that cultured keratinocytes also can be used as carriers of genes with other functions for wound healing.
CARTILAGE -RECONSTRUCTION OF THE OUTER EAR
One of the biggest challenges within reconstructive plastic surgery is the reconstruction of the outer ear after deformities (microtia) or traumatic injuries. The main alternatives until now for treatment of these conditions have been autologous rib cartilage cut and formed in the shape of the auricle or artificial implants.
Human cartilage can be divided into three types; hyaline, fibrous and elastic, all with different histology and function. The auricle is made up of soft, elastic cartilage, while the cartilage found in the ribs are of the stiffer hyaline type. The difference between cartilage type, combined with cosmetic and functional defects of the donor site, are negative implications of using rib cartilage for reconstruction of the auricle. This illustrates the need of autologous elastic cartilage as an alternative.
The development of culturing cartilaginous cells has been driven within orthopaedics, where cultured hyaline cartilaginous cells are used for treatment of damaged joint cartilage. Only recently has the interest of large amounts of tissue engineered cartilage arisen within plastic surgery.
Our group have used culture methods developed initially for hyaline cartilage to cultivate also elastic cartilage in vitro (7). To be clinically usable within reconstructive surgery it is important that the cells can be stimulated to recreate elastic cartilage of a fixed 3D shape.
To achieve this we use different types of scaffolds, which function as carriers of the chondrocytes and positive results have been reached with both collagen and fibrin-gels. Elastic chondrocytes from a millimetre-sized biopsy are expanded through culture in vitro, after which the cells are seeded into the collagen or fibrinogen solution, which then solidifies in a predetermined shape e.g. an auricle that suits the patient (Fig. 1B) .
Even if there are technical problems to overcome before grafts of cultured elastic cartilage can be used in vivo, the method has potential and can bring about dramatic changes and essentially improve reconstruction of the outer ear.
FAT -A PLASTIC SURGEONS BEST FRIEND
Attempts to treat tissue defects with autologous fat have been performed throughout the history of plastic surgery. In the beginning one tried to transplant adipose tissue en bloc and one of the more spectacular examples can be found when Czerny in 1895 tried to reconstruct the mastectomised female breast with the help of an autologous giant lipoma of the abdomen.
We know today that adipose tissue transplanted as a free graft largely goes through necrotic disintegration and leaves behind fibrous cicatrized connec-tive tissue. The death of centrally located cells are inevitable as only the peripheral cells of the free tissue graft achieve sufficient diffusion of nutritions to survive until an adequate vascularisation of the tissue takes place.
With this in mind the logical step is to increase cell survival by distributing the fat in smaller units. The first who thought of this was Schorcher who in 1957 presented the advantages to divide adipose tissue into smaller pieces before transplanting. Liposuction was put into practice within plastic surgery and gave access to an even finer dispersion of adipose tissue for transplantation, which resulted in a higher degree of survival of the transplanted tissue. Although these techniques have been refined by methods of washing/cleaning the adipose tissue and transplant/inject it through fine cannulaes a significant substance loss of about 30-70 % is to be expected and there are indications that the remaining tissue consists of mainly cicatrized connective tissue. Consequently the demand of further finely dispersed fat tissue, down to a single cell suspension level, is expected. This can be achieved through enzymatic dissociation of the tissue with e.g. collagenase. This gives the possibility to cultivate cells in vitro and thus expansion of cell numbers before transplanting.
We, as other groups, have shown the existence of a precursor cell, the pre-adipocyte, which can be cultured in vitro. Transplantation of patients' own preadipocytes, expanded in vitro, would mean that all transplanted cells get access to optimal diffusion of nutritions during the critical initial phase, with improved cell survival following (8). By using a 3D matrix, which allows diffusion, as a carrier of the cultured pre-adipocytes, large tissue defects can be treated with a high degree of cell survival (Fig. 1C) .
Unlimited access to autologous cultured adipose tissue is a powerful tool not only in plastic surgery as fat transplantation is used within all the surgical specialities and across all the different body regions.
BREAST -A METHOD WITH LARGE POTENTIAL
Reconstruction of the breast after cancer operations is a big and important task for reconstructive plastic surgery. Today methods of implantation of synthetic prosthesis or reconstruction with pedicled grafts are available.
The methods to cultivate human breast cells in a laboratory environment were developed during the 1970's and 1980's, mainly used in the studies of breast cancer development and within development of treatment methods for breast cancer. Cells can be kept viable during several generations of subcultivation and can be stimulated to differentiation with the help of pro-lactogenous hormones. With differentiation the cells become polarised and breast milk proteins can be found in the apical portions of the cells, while basement membrane proteins (e.g. laminin) are expressed in the basal portions, indicating normally functioning breast cells.
Earlier animal studies have shown that breast gland cells that are co-cultured with adipocytes form in vivo like breast gland tissue. We have recently shown that human breast gland cells can be co-cultured with human pre-adipocytes in a 3D collagen structure. In this environment and with suitable cultivation means, both cell types proliferate well and breast gland cells line up and form tubular structures (9) (Fig. 1D ). Even if no human in vivo studies have been performed, animal trials show that similar in vitro constructed "prebreasts" survive well and develop to typical breast tissue after transplantation.
The possibilities are of course enormous within the breast surgery area. Transplantation of autologous, cultured breast tissue can replace silicon implants or complicated and expensive microsurgery be avoided. Naturally one cannot ignore the enormous potential these methods have also within aesthetic surgery.
UROTHELIUM -CAN FACILITATE SEX REASSIGNMENT SURGERY
Another big problem in reconstructive plastic surgery within the urogenital area, is to recreate a functional urothelial lining in the urinary tract. Plastic surgeons meet these problems with treatment of congenital loss of part of the urethra, hypospadias, and with sex change surgery from biological woman to man. A large number of tissues are used as substitute material for urothelium: oment, deepithelialised intestine, free and pedicled skinflaps. In every case these are associated with complications as fistulas and stenosis and do not give a reliable urinary mucous membrane of optimal quality.
Relatively recently it has been shown that urothelial cells can be cultured in vitro and by using modifications of previously mentioned culture techniques get a high growth rate and cells growing in a strati- fied manner. Clinically, we initially used autologous cultured urothelial cells on cellfree dermis which functions as carrier of cells, and play the same role as does a skin graft by stimulating nearby connective tissue cells to build a supportive structure from the mucous membrane (11, 12) . To day we can culture all three cell types that builds up the urethra wall and combine them into one integrated unit with three distinct layers (Fig. 2) . We are now conducting clinical studies in hypospadia as well as sex reassignment surgery using this engineered tissue.
This method can function with reconstruction of the urethra, where the transplant is put in a well vascularised area and the transplant has contact with the receiving tissue. With the reconstruction of for example a urinary bladder, other solutions are demanded to guarantee nutrition and survival of the transplanted cells. Many ideas have been tested; among other things the possibility to combine microsurgical transferred muscle tissue with cultured urothelium.
VESSELS, NERVES AND BONE
Even if the development of tissue engineering of vessels, nerves and bone mainly have been performed by non plastic surgeons we'd like to point out the revolutionary implications these methods could have on microsurgery activities.
Medicine has strived for a long time to reduce the risks of thrombosis through lining the inside of artificial vessel grafts with autologous cultured endothelial cells and also considered the (previously) utopia of creating a cultured bloodvessel that works in vitro. Now Augers group in Canada have presented a vessel including all parts, intima, media and adventitia created through culturing cells in vitro, that functions in vivo in animal models (13) . The possibilities to fabricate fully functional autologous vessel grafts without synthetic components can help microsurgery become more flexible and open a multitude of user areas.
Within the nerve area the main objective strive to steer nerve regeneration in peripheral nerves with the help of vesselshaped synthetic tubes or cultivating supporting cells. Apart from leading regeneration in the right direction, the course of events have sped up through optimising the environment with adhesion molecules and growth factors. This solution changes dramatically in, and with, the discovery of stem cells within the nervous system (14) . Suddenly there is the possibility of culturing even these cells in vitro and there is plenty of scientific activity in this area, which can have a radical influence on, and develop possibilities within, microsurgery.
The possibility to recreate bony tissue has large potential within microsurgery even if development is mainly performed within orthopaedics and oral surgery. Today we use a wide variety of methods, which include transplant of in vitro cultivated cells, stimulated with growth factors and guided tissue regeneration with artificial material or bone mass. Through the combined advantages of these different methods we will soon have the possibility to induce and steer bony healing of fractures as with reconstruction after cancer surgery (15) .
FOETAL SURGERY
We now enter a special area of tissue engineering involving neither cultured cells nor scaffolds or regulating factors. Foetal surgery rather only adapts the timing of surgery.
While the results as regards to the skin of a foetus is a complete regeneration of all components as opposed to cicatrizing, which is the result of adult wound healing, this type of surgery can have a huge impact on plastic surgery (16) .
The mechanisms behind the foetus' special wound healing characteristics have not been explained, even if several possibilities are discussed: foetal skin cells are more undifferentiated than adults, foetal skin is surrounded by an environment with high levels of hyaluronic acid and fibronectin -both with well known effects on the wound healing process, growth factor profile differs from adult skin with amongst other things loss of one of these factors (transforming growth factor beta-1) is considered to stimulate scar building, lower oxygen tension in foetal skin can also influence healing.
Irrespective of which mechanisms lie behind, the foetal healing process involves fantastic surgical possibilities. Up to now intrauterine surgery on human foetus has above all been performed on lethal, congenital deformities. However, the interest for possibilities to intrauterine correction of lip, jaw and palate column have increased within the plastic surgery sphere (17) . The obvious advantages of scar free healing, normal development of the face and normal palate function in this patient group have initiated an intensive research around the world and even if many obstacles remain to be overcome plastic surgery reconstruction before birth is not something to attribute to science fiction but rather to a real development path.
ADULT STEMCELLS
No one can have missed the activity regarding embryonic stem cells during the last years. However, there are several major issues, ethical as well as technical, connected with these methods which so far have prevented there use when regenerating tissues.
Recently there has been a great interest in the possibility to change the fenotype of proliferating adult cells. Initially this was believed to be possible only in specialised cells in the bone marrow. However, it has recently been shown that other cells such as preadipocytes can be "transdifferentiated" into several other celltypes i.e bone, cartilage and muscle. This is to day an extremely active area and new data concerning the "stemcell potential" in different adult cell types is presented almost on a daily basis.
The possibility to use one cell type which is easy to obtain and easy to cultivate as the starting point when regenerating several different tissues would largely facilitate the transfer of tissue engineering into routine clinical practise.
EXPLOSIVE DEVELOPMENT
Tissue engineering during recent years have seen enormous developments and the possibilities in technology concede imagination. New areas unravel at a high speed and the perception is that these methods will have a huge impact on the 21 st century medical evolution. There are natural connections between the research area and plastic surgery: the first methods to develop and cultivate human tissue was aimed at plastic surgery's main organ, the skin; tissue engineering and plastic surgery have the same goal, to recreate lost and damaged tissues and organs to a functional and cosmetic optimal set; plastic surgery is one of the specialities with most potential for these new methods.
Plastic surgery will not at all be alone on the scene; other specialities have during recent years shown interest for these methods and a close working relationship with other specialities can further alleviate the introduction of these methods in clinical activities. Furthermore, many traditionally plastic surgery patients can be treated without surgical effort. On the other hand one can expect the knowledge and methods within plastic surgery to participate in the treatment of several patient groups that earlier were dealt with by other specialities.
In conclusion, reconstructive plastic surgery finds itself in front of the entrance to a new medical area with development of a new group of treatment methods, which can become one of the 21 st century's most important medical advances. This unique position not only gives plastic surgery possibilities to lead and be the driving force of developments within the area, but certainly also to mean big changes both with regard to treatment methods and patient groups to take action within reconstructive plastic surgery.
